Sulfagenix holds the key unlocking the regenerating abilities of the body. 

Sulfagenix, Inc. is built on decades of research on modifying existing molecules to improve safety, bioavailability and efficacy for new uses.

SG1002 (sodium polysulthionate), Sulfagenix’s clinical-stage prodrug, is a precursor to a natural-occurring molecule, hydrogen sulfide, for which deficits have been shown to exist in a number of serious diseases, including cardiovascular disease.

Sulfagenix Inc.

Carlos Palma

This department focuses on developing and maintaining the brand's identity and market presence.

Sulfagenix Inc.

Org chart

Teams

Brand Management

Offices

Sulfagenix Inc.

Org chart

Teams

Brand Management

Offices

Related companies